#NeuroModulation
Électrochocs et neuromodulation : en finir avec les idées reçues pour mieux soigner le cerveau
Électrochocs et neuromodulation : en finir avec les idées reçues pour mieux soigner le cerveau
l.lepoint.fr
November 9, 2026 at 10:16 AM
Fulvio Forni, Rodolphe Sepulchre: Spiking neuromodulation: a linear control perspective https://arxiv.org/abs/2611.08571 https://arxiv.org/pdf/2611.08571 https://arxiv.org/html/2611.08571
November 9, 2026 at 7:00 AM
Китайские ученые представили предварительные результаты пилотных клинических испытаний хемогенетической нейромодуляции при устойчивой к терапии эпилепсии. У пациентов значительно уменьшилась частота приступов и их тяжесть

https://nplus1.ru/news/2026/11/09/chemogenetic-neuromodulation-ga002
November 9, 2026 at 4:25 PM
Honored to receive this recognition of our work, and deeply grateful to my mentors and the entire Lifespan Neuromodulation team for their support & collaboration along the way!
November 3, 2026 at 12:03 PM
Spinal Cord Stimulation uses mild electrical impulses to modulate pain signals and help manage certain types of chronic pain.

Discover more about neuromodulation at 2027WIPN

Sept 16-17, 2027 | Singapore + Online
worldpainmedicine.org

#2027WIPN #Neuromodulation #hybrid
November 9, 2026 at 1:05 PM
#FBF2024: Neuromodulation and Functional Gastrointestinal Disease

👀 https://bit.ly/48m8rhX

➡️ DOI: 10.1016/j.neurom.2023.08.001

#Neuromodulation #GutBrainAxis #Gastroenterology #VagusNerveStimulation #FGID
November 6, 2026 at 4:42 PM
I know it likely feels early to many people, but today I finished most of my planning for the holiday season. I'm anticipating having my sacral neuromodulation surgeries in December, but I don't want to miss out on anything. So I have my lists and I may start cookies this weekend. 🎅
November 9, 2026 at 10:47 PM
Just wow. I remember people talking about therapies when DREADDs first arrived and thinking they were nuts.

Seriously wow and yay science 🧠🧪. While these are trying times, I have such optimism and excitement for where we are as a field.

www.nejm.org/doi/abs/10.1...
Chemogenetic Neuromodulation for Refractory Epilepsy | NEJM
In three patients with refractory epilepsy, hippocampal chemogenetic therapy plus low-dose clozapine was associated with a mean seizure-frequency reduction of 92.6%. Adverse events were grade 1 or 2.
www.nejm.org
November 5, 2026 at 12:53 AM
👍Chemogenetic Neuromodulation for Refractory Epilepsy | New England Journal of Medicine www.nejm.org/doi/10.1056/...
Chemogenetic Neuromodulation for Refractory Epilepsy | NEJM
In three patients with refractory epilepsy, hippocampal chemogenetic therapy plus low-dose clozapine was associated with a mean seizure-frequency reduction of 92.6%. Adverse events were grade 1 or 2.
www.nejm.org
November 9, 2026 at 5:31 PM
Pain management goes beyond medication.

Explore interventional approaches such as nerve blocks, radio frequency ablation, and spinal cord stimulation at 2027WIPN.

📅 September 16-17, 2027 | Singapore + Online

🌐 worldpainmedicine.org

#2027WIPN #PainMedicine #Neuromodulation
November 7, 2026 at 8:21 AM
Exciting to see @doriswang.bsky.social's research showing how deep brain stimulation (DBS) can be synchronized to the dynamics of walking featured in @nature.com! Their recent study represents a new chapter for personalized neuromodulation for #Parkinsons. 🧠📈 🧪 www.nature.com/articles/d41...
Six highlights from Parkinson’s disease research
Targeting a new network, addressing gait issues and other advances from recent studies.
www.nature.com
November 5, 2026 at 7:20 PM
🔄 Updated Arxiv Paper

Title: Spiking neuromodulation: a linear control perspective
Authors: Fulvio Forni, Rodolphe Sepulchre

Read more: https://arxiv.org/abs/2611.08571
November 9, 2026 at 8:02 AM
November is Complex Regional Pain Syndrome (CRPS) Awareness Month, the next installment in the International Neuromodulation Society's series highlighting global health awareness days relevant to neuromodulation.

#CRPSAwarenessMonth #CRPSOrangeDay #Neuromodulation #PainManagement
November 4, 2026 at 4:02 PM
neuromodulation (including neurofeedback and neurostimulation), and consciousness science, as well as research examining the broader implications of advanced meditation for the mind, body, consciousness, eudaimonia, well-being and thriving, and beyond.
November 9, 2026 at 2:02 PM
Individualized AI-driven Neuromodulation Selectively Enhances and Reorganizes Human Tongue Sensorimotor Networks. https://www.biorxiv.org/content/10.64898/2026.11.04.764393v1
November 6, 2026 at 2:16 AM
Focused ultrasound neuromodulation and longitudinal precision functional mapping may improve psychiatric research and enable future treatments for severe illnesses.
Save What Matters
Curate Feeds | Make Collections | Customize Email Briefs
briefly.co
November 9, 2026 at 5:22 PM
Focused ultrasound neuromodulation and longitudinal precision functional mapping may improve psychiatric research and enable future treatments for severe illnesses.
Save What Matters
Curate Feeds | Make Collections | Customize Email Briefs
briefly.co
November 9, 2026 at 5:22 PM
Non pharmacologic therapies for fibromyalgia - vs JAMA review article in 2014

#ACR26 #GlobalSummit
November 6, 2026 at 6:30 PM
Extremely low-frequency magnetic field neuromodulation in humans: from magnetophosphene perception to peripheral sensory activation

by Fresnel E 2026 [PhD Thesis]

uwo.scholaris.ca/items/f57a12...

⚡🧠 🧲 #TMS #BrainStim
Home Page
doi.org
November 5, 2026 at 7:31 AM
Individualized AI-driven Neuromodulation Selectively Enhances and Reorganizes Human Tongue Sensorimotor Networks. #NeuroDegeneration 🧪🧠
https://www.biorxiv.org/content/10.64898/2026.11.04.764393v1
November 6, 2026 at 5:02 AM
Individualized AI-driven Neuromodulation Selectively Enhances and Reorganizes Human Tongue Sensorimotor Networks. https://www.biorxiv.org/content/10.64898/2026.11.04.764393v1
November 6, 2026 at 2:16 AM
I had no idea that DREADDs even made it to the clinic. And at first glance, they seem to be safe and work well.
cen.acs.org/pharmaceutic...

www.nejm.org/doi/full/10....
Chemogenetic Neuromodulation for Refractory Epilepsy | NEJM
In three patients with refractory epilepsy, hippocampal chemogenetic therapy plus low-dose clozapine was associated with a mean seizure-frequency reduction of 92.6%. Adverse events were grade 1 or 2.
www.nejm.org
November 5, 2026 at 8:34 AM
🤝 We’re pleased to welcome Kind Congress as a Media Partner for the 2027 World Conference on Interventional Pain Medicine & Neuromodulation (2027WIPN)!

🌐 worldpainmedicine.org

#2027WIPN #MediaPartner #PainMedicine #Neuromodulation #Singapore #hybridconference
November 4, 2026 at 1:03 PM